Dear Policyholders,

OMIC claims data indicates that ophthalmologists who do not properly screen patients for bleeding risks and manage hemorrhage when it occurs often face malpractice lawsuits. “Hemorrhage associated with ophthalmic procedures” presents a case study, and detailed discussions of how to screen patients who may be at increased risk for hemorrhage, monitor for signs and symptoms of hemorrhage, and begin to manage an orbital compartment syndrome.

OMIC Board Member Dr. Ronald Pelton co-authored the article and shared his anticoagulant forms. You may access the recommendations, anticoagulant list, anticoagulant form for patients, and anticoagulant consent form at https://www.omic.com/hemorrhage-associated-with-ophthalmic-procedures/.

Sincerely,

Anne M. Menke, RN, PhD
OMIC Patient Safety Manager

CONFIDENTIALITY NOTICE: This correspondence is intended only for the person or entity to which it is addressed and may contain information that is privileged, confidential or otherwise protected from disclosure. Dissemination, distribution or copying of this e-mail or the information herein by anyone other than the intended recipient, or an employee or agent responsible for delivering the message to the intended recipient, is prohibited. If you have received this e-mail in error, please notify us at riskmanagement@omic.com and destroy the original message and all copies.
______________________________________________
As long as we have a current email address for you, you will automatically receive this message. If you do not wish to receive the E-Bulletin, please click the reply button and write REMOVE in the subject line or email omic@omic.com.